首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert review of molecular diagnostics

缩写:EXPERT REV MOL DIAGN

ISSN:1473-7159

e-ISSN:1744-8352

IF/分区:3.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2075
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Zoran Gluvić,Sonja Zafirović,Emina Sudar-Milovanović et al. Zoran Gluvić et al.
Introduction: New research has shown an intriguing link between the gut bacteria and the thyroid. A gut-thyroid relationship affects energy production, immunological function, and inflammation. As a result, disrupted gut ...
Rezhat Abbas,Nazifa Javaid Rezhat Abbas
Background: Oral squamous cell carcinoma, the most common head and neck cancer, is characterized by aggressive invasion, frequent lymph node metastasis, and high recurrence. ...
Yasminn Meireles,Carlos Pilotto Heming,Veronica Aran Yasminn Meireles
Background: This systematic review and meta-analysis of diagnostic test accuracy evaluated the performance of noninvasive liquid biopsy methods for diagnosis of meningioma, the most common primary intracranial neoplasm in...
Peter J Kitonsa,Devan Jaganath Peter J Kitonsa
Introduction: Pediatric tuberculosis (TB), especially among children co-infected with HIV, remains a significant global health challenge. Traditional sputum-based diagnostics are less effective in this population due to d...
Malihe Lotfi,Zahra Farshchian Yazdi,Mohammad Reza Hashemi et al. Malihe Lotfi et al.
Introduction: CRISPR-based genome editing has revolutionized molecular diagnostics and therapeutic applications, offering precise genetic modifications. However, off-target effects remain a significant challenge, potentia...
Jennifer Scott,Ana Machado,Agostinho Carvalho et al. Jennifer Scott et al.
Introduction: Invasive fungal infections (IFIs) remain a major clinical challenge due to the expansion of high-risk patient groups and drawbacks of conventional diagnostics which contribute to the devastating mortality ra...
Jan Trøst Jørgensen,Kristian Egebjerg Jan Trøst Jørgensen
Introduction: HER2-targeted antibody-drug conjugates (ADCs) have shown promising outcomes in the treatment of patients with various HER2-expressing solid tumors. The efficacy of ADCs is influenced by several factors, such...
Alexander Yarunin,Hanna Ahlgren,Moumita Chaki et al. Alexander Yarunin et al.
Introduction: Aromatase inhibitors (AI) plus CDK4/6 inhibitors are the current first-line standard-of-care for hormone receptor (HR)-positive/HER2-negative advanced breast cancer (ABC). However, mutations in ESR1 (ESR1m),...
Arman Rahman,Chee Leong Cheng,Reza Salim et al. Arman Rahman et al.
Introduction: Molecular diagnostics in Low- and Middle-Income Countries (LMICs) face significant barriers: limited expertise, geographical access, and infrastructure. These impede effective disease management and public h...